Virta Health is now prescribing GLP-1s to treat obesity alongside its diabetes-reversal program. Virta says it's doing $100 million in annual recurring revenue and seeing its growth accelerate ...

Company expands its Sustainable Weight Loss offering with Responsible Prescribing capabilities to help organizations lower GLP-1 costs while improving outcomes DENVER, January 10, 2025--(BUSINESS ...

Revenue Growth Surges to 80% Year-over-Year, Fueled by Demand for Virta’s Transformational and Cost-Effective Weight Loss Results DENVER, April 04, 2025--(BUSINESS WIRE)--Virta Health ...